Top Markets
#1 EXOD EXOD +56.80%
#2 Arowana Arowana +8.49%
#3 Fake World Assets Fake World Assets +8.26%
#4 Perle Perle +3.98%
#5 Not in Employment, Education, or Training Not in Employment, Education, or Training +3.72%
#6 Dual Dual +3.58%
#7 Casper Network Casper Network +3.58%
#8 Figure Heloc Figure Heloc +3.49%
#9 Movement Movement +3.23%
#10 Orochi Network Orochi Network +3.13%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
Ra Medical Systems, Inc. Ra Medical Systems, Inc.

Ra Medical Systems, Inc.

RMED
Rank in Stocks #38063
Ra Medical Systems, Inc. operates as a medical technology enterprise... Ra Medical Systems, Inc. operates as a medical technology enterprise specializing in the creation, production, and sale of excimer lasers. These lasers are specifically designed for the management of vascular conditions linked to immune-mediated inflammation. Among its key offerings is the DABRA system, a minimally invasive solution that utilizes an excimer laser and a disposable catheter. This innovative technology enables physicians to perform endovascular treatments, effectively clearing arteriosclerotic blockages in the lower extremities, which are often a result of lower extremity vascular disease, through laser radiation ablation. The company primarily channels its products to the U.S. market through a network of distributors. Founded in 2002, Ra Medical Systems' corporate base is located in Carlsbad, California.
Share Price
$0.575
Last synced: 2023-09-15
Market Cap
$1.24M
Change (1 day)
9.00%
Change (1 year)
0.00%
Country
US
Trade Ra Medical Systems, Inc. (RMED)

Category

Healthcare
P/E ratio for Ra Medical Systems, Inc. (RMED)
P/E ratio as of 2026 TTM: 0
According to Ra Medical Systems, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Ra Medical Systems, Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 33.99 -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 33.47 -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 21.39 -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 18.84 -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 49.47 -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.